General Information of This Metabolic Reaction (MR) (ID:
MR000158) |
Formula |
|
Reactant |
Alogliptin |
Product |
Alogliptin M2 |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 2D6 (CYP2D6)
|
DME Info
|
Metabolic Type
|
Oxidation
-
Deamination
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus. Clin Exp Pharmacol Physiol. 2015 Dec;42(12):1225-38.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.